The lawsuit, spearheaded by the Law Offices of Howard G. Smith, claims that the company misled shareholders regarding its operational integrity. Specifically, the complaint alleges that Hims & Hers shared sensitive consumer health data with third-party advertising platforms without proper disclosure. Furthermore, the firm is accused of charging customers for prescriptions immediately following intake form submissions, contradicting public claims that patients would first consult with medical providers to determine appropriate treatments.
Investors Face November Deadline in Hims & Hers Securities Lawsuit
Investors who incurred significant losses in Hims & Hers Health, Inc. stock between August 2025 and July 2026 now have until November 2, 2026, to file as lead plaintiffs in a pending securities fraud class action. The litigation centers on allegations of deceptive business practices and undisclosed regulatory risks.
These omissions allegedly exposed the company to heightened regulatory scrutiny and potential financial penalties, undermining the accuracy of previous statements concerning the firm’s business prospects. Investors seeking to participate or review their legal standing may contact Howard G. Smith at 215-638-4847 or via the firm's website. Participation in this class action does not require immediate action, as shareholders may choose to retain their own counsel or remain passive members of the existing litigation.
Comments (0)
No comments yet. Be the first!